EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPMAG00000003796
Gene Symbol: DHCR24
1 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase A

Ensembl ID : ENSPMAG00000009073
Gene Symbol: HMGCRA
1 Cross references
269 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSPMAG00000009405
Gene Symbol: PDPK1B
1 Cross references
243 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSPMAG00000006283
Gene Symbol: HTR2B
1 Cross references
440 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSPMAG00000010171
Gene Symbol: HTR1F
2 Cross references
296 Possible Orthologues:

5-Hydroxytryptamine Receptor 3a

Ensembl ID : ENSPMAG00000007406
Gene Symbol: HTR3A
1 Cross references
219 Possible Orthologues:

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSPMAG00000003070
Gene Symbol: HTR4
1 Cross references
274 Possible Orthologues:

5-Hydroxytryptamine Receptor 5a

Ensembl ID : ENSPMAG00000005791
Gene Symbol: HTR5A
1 Cross references
293 Possible Orthologues:

Abl Proto-Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSPMAG00000004997
Gene Symbol: ABL1
1 Cross references
412 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSPMAG00000007275
Gene Symbol: APEX1
1 Cross references
212 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSPMAG00000001941
Gene Symbol: APH1B
1 Cross references
5 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSPMAG00000004590
Gene Symbol: APH1B
2 Cross references
4 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).